2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Advances in systemic therapy for non-small cell lung cancer

M Miller, N Hanna - Bmj, 2021 - bmj.com
Lung cancer remains a leading cause of cancer related mortality worldwide. Despite
numerous advances in treatments over the past decade, non-small cell lung cancer …

Geriatric assessment–driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial

D Li, CL Sun, H Kim, E Soto-Perez-de-Celis… - JAMA …, 2021 - jamanetwork.com
Importance Although geriatric assessment–driven intervention improves patient-centered
outcomes, its influence on chemotherapy-related toxic effects remains unknown. Objective …

Stress and cancer: mechanisms, significance and future directions

A Eckerling, I Ricon-Becker, L Sorski… - Nature Reviews …, 2021 - nature.com
The notion that stress and cancer are interlinked has dominated lay discourse for decades.
More recent animal studies indicate that stress can substantially facilitate cancer …

Treatment of epithelial ovarian cancer

L Kuroki, SR Guntupalli - Bmj, 2020 - bmj.com
Ovarian cancer is the third most common gynecologic malignancy worldwide but accounts
for the highest mortality rate among these cancers. A stepwise approach to assessment …

[HTML][HTML] Non-small-cell lung cancer in 2022: a review for general practitioners in oncology

H Mithoowani, M Febbraro - Current Oncology, 2022 - mdpi.com
Lung cancer is the leading cause of cancer death in Canada and a significant cause of
morbidity for patients and their loved ones. There have been rapid advances in preventing …

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D Planchard, ST Popat, K Kerr, S Novello… - Annals of …, 2018 - annalsofoncology.org
Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …

[HTML][HTML] The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions

KE Sleeman, M De Brito, S Etkind, K Nkhoma… - The Lancet Global …, 2019 - thelancet.com
Background Serious life-threatening and life-limiting illnesses place an enormous burden on
society and health systems. Understanding how this burden will evolve in the future is …

Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology

RA Swarm, JA Paice, DL Anghelescu, M Are… - Journal of the National …, 2019 - jnccn.org
In recent years, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for
Adult Cancer Pain have undergone substantial revisions focusing on the appropriate and …

[HTML][HTML] Paracetamol: a review of guideline recommendations

U Freo, C Ruocco, A Valerio, I Scagnol… - Journal of clinical …, 2021 - mdpi.com
Musculoskeletal pain conditions are age-related, leading contributors to chronic pain and
pain-related disability, which are expected to rise with the rapid global population aging …